Article
Improvement in Psoriasis During Rituximab Therapy for Mixed Cryoglobulinemia Type II
- Author:
- Moberg P
- Charles JF
- Respicio G
- Venna SS
- Rooney T
Rituximab is a B-cell depleting monoclonal antibody targeting CD20. Data concerning the behavior of psoriatic disease following rituximab therapy...